Xenon as neuroprotectant in acute stroke?

被引:8
作者
Altschuler, EL [1 ]
机构
[1] Univ Calif San Diego, Brain & Percept Lab, La Jolla, CA 92093 USA
关键词
D O I
10.1054/mehy.2000.1159
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Stroke is one of the most common diseases worldwide. A current focus of research is to find neuroprotectants that can be given during acute stroke. One specific target is to find antagonists of the N-methyl-D-aspartate (NMDA) receptor in an attempt to limit glutamate associated neurotoxicity. Xenon has recently been found to be an NMDA receptor antagonist. I suggest that xenon be considered as a neuroprotectant in acute stroke, and discuss methods of testing this proposal. (C) 2001 Harcourt Publishers Ltd.
引用
收藏
页码:227 / 228
页数:2
相关论文
共 7 条
[1]   Rehabilitation of hemiparesis after stroke with a mirror [J].
Altschuler, EL ;
Wisdom, SB ;
Stone, L ;
Foster, C ;
Galasko, D ;
Llewellyn, DME ;
Ramachandran, VS .
LANCET, 1999, 353 (9169) :2035-2036
[2]   THE ANESTHETIC PROPERTIES OF XENON IN ANIMALS AND HUMAN BEINGS, WITH ADDITIONAL OBSERVATIONS ON KRYPTON [J].
CULLEN, SC ;
GROSS, EG .
SCIENCE, 1951, 113 (2942) :580-582
[3]   How does xenon produce anaesthesia? [J].
Franks, NP ;
Dickinson, R ;
de Sousa, SLM ;
Hall, AC ;
Lieb, WR .
NATURE, 1998, 396 (6709) :324-324
[4]  
Gengo FM, 1998, PHARMACOTHERAPY, V18, p101S
[5]  
Kwatkowski TG, 1999, NEW ENGL J MED, V340, P1781
[6]  
LAWRENCE JH, 1947, J PHYSIOL-LONDON, V105, P197
[7]  
TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347